High Heterogeneity of Multidrug-Resistant


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
27 01 2020
Historique:
received: 15 07 2019
accepted: 12 11 2019
pubmed: 27 11 2019
medline: 26 11 2020
entrez: 27 11 2019
Statut: epublish

Résumé

Multidrug-resistant

Identifiants

pubmed: 31767720
pii: AAC.01415-19
doi: 10.1128/AAC.01415-19
pmc: PMC6985730
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Cephalosporins 0
Culture Media 0
beta-Lactams 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI137269
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI124275
Pays : United States

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Cell Host Microbe. 2017 May 10;21(5):592-602.e4
pubmed: 28494240
J Med Microbiol. 2015 Jul;64(7):676-81
pubmed: 25934549
J Clin Microbiol. 2018 Feb 22;56(3):
pubmed: 29237787
Clin Infect Dis. 2005 May 1;40(9):1333-41
pubmed: 15825037
Infect Control Hosp Epidemiol. 2013 Oct;34(10):1070-6
pubmed: 24018924
Clin Infect Dis. 2019 May 30;68(12):2053-2059
pubmed: 30239622
Antimicrob Agents Chemother. 2005 Aug;49(8):3513-6
pubmed: 16048971
JAMA. 2018 Sep 11;320(10):984-994
pubmed: 30208454
Arch Intern Med. 2011 Mar 28;171(6):491-4
pubmed: 21444840
Chemotherapy. 2002;48(6):280-97
pubmed: 12673103
N Engl J Med. 2000 Dec 28;343(26):1925-32
pubmed: 11136263
Infect Control Hosp Epidemiol. 2003 Sep;24(9):644-9
pubmed: 14510245
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):355-60
pubmed: 21052757
Clin Infect Dis. 2017 Jul 15;65(2):208-215
pubmed: 28369261
J Antimicrob Chemother. 2008 Nov;62(5):1142-9
pubmed: 18641033
Clin Infect Dis. 2012 Oct;55(7):905-14
pubmed: 22718773
Antimicrob Agents Chemother. 2003 Nov;47(11):3610-2
pubmed: 14576127
Transpl Infect Dis. 2014 Feb;16(1):84-9
pubmed: 24330161
Int J Antimicrob Agents. 2003 Jul;22(1):28-34
pubmed: 12842325
Eur J Clin Microbiol. 1984 Oct;3(5):475-7
pubmed: 6594237
Scand J Infect Dis. 1992;24(2):209-13
pubmed: 1322559
PLoS One. 2015 Oct 02;10(10):e0139883
pubmed: 26431402
J Antimicrob Chemother. 1988 Jan;21 Suppl A:1-13
pubmed: 2965119
Antimicrob Agents Chemother. 1986 Feb;29(2):225-9
pubmed: 3087275
Clin Pharmacokinet. 2000 Sep;39(3):167-83
pubmed: 11020133
J Antimicrob Chemother. 2017 Jan;72(1):128-136
pubmed: 27707993
Clin Infect Dis. 2018 Nov 13;67(11):1720-1728
pubmed: 29701766
Clin Microbiol Infect. 2014 Aug;20(8):O508-15
pubmed: 24450760
Infect Immun. 2013 Mar;81(3):965-73
pubmed: 23319552
Clin Microbiol Rev. 2013 Jul;26(3):526-46
pubmed: 23824372

Auteurs

Ana Djukovic (A)

Centro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain.

Eva M González-Barberá (EM)

Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Jaime Sanz (J)

Hospital Universitari i Politècnic La Fe, Valencia, Spain.
CIBERONC, Instituto Carlos III, Madrid, Spain.

Alejandro Artacho (A)

Centro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain.

Iván Peñaranda (I)

Centro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain.

Beatriz Herrera (B)

Centro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain.

María José Garzón (MJ)

Centro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain.

Miguel Salavert (M)

Hospital Universitari i Politècnic La Fe, Valencia, Spain.

José Luis López-Hontangas (JL)

Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Karina B Xavier (KB)

Instituto Gulbenkian de Ciência, Oeiras, Portugal.

Bernhard Kuster (B)

Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.

Laurent Debrauwer (L)

Toxalim-Research Center in Food Toxicology, Toulouse University, INRA UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, Toulouse, France.
Axiom Platform, UMR 1331 Toxalim, MetaToul-MetaboHUB, National Infrastructure of Metabolomics and Fluxomics, Toulouse, France.

Jean-Marc Rolain (JM)

Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

Miguel A Sanz (MA)

Hospital Universitari i Politècnic La Fe, Valencia, Spain.
CIBERONC, Instituto Carlos III, Madrid, Spain.

Joao B Xavier (JB)

Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Computational and Systems Biology Program, Sloan-Kettering Institute, New York, New York, USA.

Carles Ubeda (C)

Centro Superior de Investigación en Salud Pública-FISABIO, Valencia, Spain ubeda_carmor@gva.es.
Centers of Biomedical Research Network (CIBER) in Epidemiology and Public Health, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH